Circle Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,368
Closed -$203K 166
2022
Q4
$203K Buy
+2,368
New +$188K 0.03% 157
2021
Q1
Sell
-10,084
Closed -$587K 180
2020
Q4
$587K Sell
10,084
-67
-0.7% -$4.04K 0.08% 134
2020
Q3
$641K Sell
10,151
-1,792
-15% -$124K 0.11% 96
2020
Q2
$919K Sell
11,943
-2,083
-15% -$160K 0.16% 66
2020
Q1
$1.05M Buy
14,026
+458
+3% +$31.6K 0.2% 60
2019
Q4
$882K Sell
13,568
-1,351
-9% -$88K 0.15% 75
2019
Q3
$946K Sell
14,919
-2,993
-17% -$196K 0.2% 63
2019
Q2
$1.21M Buy
17,912
+976
+6% +$64.2K 0.26% 55
2019
Q1
$1.1M Buy
+16,936
New +$1.13M 0.25% 65

Other funds holding GILD

Circle Wealth Management's GILD Position: Q1 2023 in Review

Circle Wealth Management sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 2,368 shares — an estimated $203K sold.

Circle Wealth Management first reported a position in GILD in Q1 2019 and held it in 9 quarters. The position peaked at $1.21M in Q2 2019. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

  • Circle Wealth Management reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
  • Circle Wealth Management sold 2,368 Gilead Sciences shares in Q1 2023, an estimated $203K.
  • Circle Wealth Management first reported a position in Gilead Sciences in Q1 2019 and held it in 9 quarters.
  • Circle Wealth Management's Gilead Sciences position peaked at $1.21M in Q2 2019.
  • 1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Circle Wealth Management's 13F filing for Q1 2023, filed 9 May 2023.